Comments
Loading...

Aileron Therapeutics

ALRNNASDAQ
Logo brought to you by Benzinga Data
$3.02
-0.34-10.12%
Last update: 11:33 AM
15 minutes delayed

Aileron Therapeutics (NASDAQ:ALRN) Stock Quotes, Forecast and News Summary

Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.

Open$3.33
Close-
Volume / Avg.18.36K / 71.77K
Day Range$2.86 - $3.33
52 Wk Range1.01 - 7.42
Market Cap$65.43M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
53
Short Interest
1.19%
Days to Cover7.32
About Aileron Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALRN
RENB

FAQ

Q

How do I buy Aileron Therapeutics (ALRN) stock?

A

You can purchase shares of Aileron Therapeutics (NASDAQ:ALRN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aileron Therapeutics (ALRN) competitors?

Q

What is the forecast, or price target, for Aileron Therapeutics (ALRN) stock?

A

Aileron Therapeutics has a consensus price target of $10.00.

Q

What is the current price for Aileron Therapeutics (ALRN)?

A

The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $3.02 last updated September 25, 2024 at 11:33 AM EDT.

Q

Does Aileron Therapeutics (ALRN) pay a dividend?

A

There are no upcoming dividends for Aileron Therapeutics.

Q

When is Aileron Therapeutics (NASDAQ:ALRN) reporting earnings?

A

Aileron Therapeutics’s Q3 earnings are confirmed for Friday, October 11, 2024.

Q

Is Aileron Therapeutics (ALRN) going to split?

A

There is no upcoming split for Aileron Therapeutics.

Q

What sector and industry does Aileron Therapeutics (ALRN) operate in?

A

Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch